Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluocinolone acetonide, hydroquinone and tretinoin cream for moderate-to-severe melasma
CTR20200866Phase 3Completed
- Sponsor
- Zhejiang Funuo Pharmaceutical
- Start
- Aug 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of fluocinolone acetonide + hydroquinone + tretinoin in melasma, sponsored by Zhejiang Funuo Pharmaceutical. Started Aug 2020; status: completed.
02
Drugs
fluocinolone acetonide + hydroquinone + tretinoin
03
Conditions
melasma
Beyond the preview
Go deeper on CTR20200866.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20200866.